4/A//SEC Filing
Truong Vu 4/A
Accession 0001104659-19-047881
CIK 0001614067other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 11:40 AM ET
Size
5.5 KB
Accession
0001104659-19-047881
Insider Transaction Report
Form 4/AAmended
Truong Vu
DirectorCEO, CSO, Director10% Owner
Transactions
- Award
Stock Options
2019-02-20+200,000→ 496,050 totalExercise: $8.20Exp: 2029-02-20→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]The Stock Options vest in equal installments over 48 months, beginning on March 20, 2019.
- [F2]The original form 4 reported the exercise price as $8.46. The original form 4 also reported the number of derivative securities beneficially owned following the reported transaction as 316,861.
Documents
Issuer
Aridis Pharmaceuticals, Inc.
CIK 0001614067
Entity typeother
Related Parties
1- filerCIK 0001749993
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 11:40 AM ET
- Size
- 5.5 KB